Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMURF1 is an E3 ubiquitin ligase that negatively regulates the BMP and TGF-beta signaling pathways by ubiquitinating and targeting key signaling molecules, such as R-SMADs and receptors, for proteasomal degradation. It plays diverse roles in cellular physiology, including cell growth, morphogenesis, migration, and development, and is implicated in various diseases, including cancer, cardiovascular diseases, and immune disorders. Its activity is regulated by phosphorylation and interactions with substrates and adaptors.
E3 ubiquitin ligase mediating the transfer of ubiquitin to substrate proteins, targeting them for proteasomal degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Smad Ubiquitination Regulatory Factor 1.